23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company, today released a new report as part of the 23andMe+ sub...
Deloitte is proud to announce the launch of "Illustrate Change," a project that seeks to build momentum around representation in medical illustrations and ...
Joining ReMY on the round were new investors Boro Capital, Supernode Ventures, MedMountain Ventures, The Triangle Tweener Fund, David Golan, and Silic...
Safety data encouraging with no graft-versus-host-disease and no neurotoxicity Updated data highlighted in podium presentation at the 17th International...
This study, conducted by experts from Aquarius Population Health Limited in London and the University of Manchester, presents valuable insights into the co...
According to a recent report by the Centers for Disease Control and Prevention (CDC), 1 in 36 children in the U.S. is diagnosed with an autism spectrum dis...
After four years of follow-up, KEYTRUDA plus LENVIMA reduced the risk of death by 21% versus sunitinib in the pivotal Phase 3 CLEAR (Study 307)/KEYNOTE-581...
In contrast to the success of CAR T-cell therapies in liquid cancers, development for the treatment of solid tumors, including glioblastoma, has progressed...
Published online May 16 in the journal Cell, the report describes the molecular mechanism behind a DNA repair pathway that counters the mistaken inclusion ...
Key Advantages of Using In Vivo Fluorescence Imaging Non-invasive approach In vivo fluorescence imaging is a non-invasive technique that uses light to vi...
Two newly published pieces indicate that the ophthalmology community is more broadly embracing myopia control and management, according to global cat...
Largely driven by increasing incidence of chronic and infectious diseases and growth in biotechnology and pharma industries, the global immunoassay market ...
There is growing recognition that the experimental model systems used in many cancer research projects, which include 2D cell cultures, patient-derived xen...
More than a million years ago, large chunks of the human genome were rearranged—a chance event during egg or sperm formation that led to the deletion...
© 2025 Biopharma Boardroom. All Rights Reserved.
